35954-65-5,
2-METHYL-(3,4,6-TRI-O-ACETYL-1,2-DIDEOXY-ALPHA-D-GLUCOPYRANO)-[2,1-D]-2-OXAZOLINE,
2-Methyl-(3,4,6-tri-O-acetyl-1,2-dideoxy-a-D-glucopyrano)-[2,1-d]-2-oxazoline,
WZFQZRLQMXZMJA-KSTCHIGDSA-N,
WZFQZRLQMXZMJA-KSTCHIGDSA-,
DTXSID70432379,
MFCD18643061,
ZINC22063830,
K-8086,
W-202489,
1-O,N,N-Ethylidyne-alpha-D-glucosamine 3,4,6-triacetate,
2-Methyl-4,5-(3,4,6-tri-O-acetyl-2-deoxy-|A-D-glucopyrano)-| currency2-oxazoline,
(3aR,5R,6S,7R,7aR)-5-[(Acetyloxy)methyl]-2-methyl-5,6,7,7a-tetrahydro-3aH-pyrano[3,2-d][1,3]oxazole-6,7-diyl diacetate,
InChI=1/C14H19NO8/c1-6-15-11-13(22-9(4)18)12(21-8(3)17)10(5-19-7(2)16)23-14(11)20-6/h10-14H,5H2,1-4H3/t10-,11-,12-,13-,14+/m1/s1,
CID9883925,
2-Methyl-4,5-[3,4,6-O-triacetyl-d-glucopyranose]-2-oxazolidine,
2-Methyl-4,5-(3,4,6-tri-O-acetyl-2-deoxy-a-D-glucopyrano)-2-oxazoline,
5H-Pyrano[3,2-d]oxazole-6,7-diol, 5-[(acetyloxy)methyl]-3a,6,7,7a-tetrahydro-2-methyl-, diacetate (ester), [3aR-(3a.alpha.,5.alpha.,6.beta.,7.alpha.,7a.alpha.)]-,